Brief: Trendlines Group Says Portfolio Co Received Regulatory Clearance From US FDA For Composite Sinus Stent
03/01/2018 10:25
Jan 3 (Reuters) - Trendlines Group Ltd THET.SI :
* PORTFOLIO CO RECEIVED REGULATORY CLEARANCE FROM UNITED
STATES
FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS COMPOSITE SINUS
STENT
Source text for Eikon: ID:nSN6RzdPC
Further company coverage: THET.SI
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Trendlines
See all newsBrief: Trendlines Group Says Elastimed Enters Strategic U.S. Distribution Agreement
Brief: Trendlines Updates On Israel Situation
Brief: Trendlines Group Proposes Placement Of Up To 83.7 Mln New Shares
Brief: Trendlines Group Appoints Orit Alaluf Cohen As CFO
Brief: Trendlines Group Says Individuals To Subscribe Up To 51.4 MLN Shares At S$0.0666 Per Share